ES8301244A1 - Procedimiento para la obtencion de derivados de sisomicina. - Google Patents

Procedimiento para la obtencion de derivados de sisomicina.

Info

Publication number
ES8301244A1
ES8301244A1 ES508803A ES508803A ES8301244A1 ES 8301244 A1 ES8301244 A1 ES 8301244A1 ES 508803 A ES508803 A ES 508803A ES 508803 A ES508803 A ES 508803A ES 8301244 A1 ES8301244 A1 ES 8301244A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
derivatives
sisomicin
sisomicin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508803A
Other languages
English (en)
Other versions
ES508803A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8301244A1 publication Critical patent/ES8301244A1/es
Publication of ES508803A0 publication Critical patent/ES508803A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE SISOMICINA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES DE FORMULA (I), EN LA QUE R ES UN RADICAL DE FORMULA <024>A<024>XH, DONDE A ES ALQUILENO O ALQUENILENO C <003> SUSTITUIDO POR 2 A 7 HIDROXILOS; Y X ES OXIGENO O <024>NR , SIENDO R HIDROGENO, ALQUILO O HIDROXIALQUILO C <003> O ARALQUILO C <003> . CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN AGENTE DE ACILACION DE FORMULA G<024>CO<024>OR'', EN LAS QUE G ES UN GRUPO DE SALIDA; R'' ES R O R PROTEGIDO; Y R , R R, R Y R SON GRUPOS PROTECTORES DE AMINA. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, EN CASO NECESARIO EN PRESENCIA DE ACEPTORES DE ACIDOS, A TEMPERATURAS ENTRE -30<025>C Y 80<025>C. >ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA COMBATIR AFECCIONES BACTERIALES.
ES508803A 1981-01-17 1982-01-15 Procedimiento para la obtencion de derivados de sisomicina. Granted ES508803A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813101376 DE3101376A1 (de) 1981-01-17 1981-01-17 Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8301244A1 true ES8301244A1 (es) 1982-11-16
ES508803A0 ES508803A0 (es) 1982-11-16

Family

ID=6122815

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508803A Granted ES508803A0 (es) 1981-01-17 1982-01-15 Procedimiento para la obtencion de derivados de sisomicina.

Country Status (7)

Country Link
US (1) US4438260A (es)
EP (1) EP0056575A1 (es)
JP (1) JPS57139093A (es)
AU (1) AU7885281A (es)
DE (1) DE3101376A1 (es)
DK (1) DK16982A (es)
ES (1) ES508803A0 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2174583A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulfuric acid esters of sugar alcohols
US7794713B2 (en) * 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US20080213274A1 (en) * 2005-10-28 2008-09-04 Sabbadini Roger A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
CA2706369C (en) * 2007-11-21 2014-03-25 Achaogen, Inc. Antibacterial aminoglycoside analogs
WO2010132760A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of tobramycin
WO2010132768A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of sisomicin
WO2010132757A2 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial aminoglycoside analogs
WO2010132759A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of dibekacin
WO2010132765A2 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial aminoglycoside analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207582A1 (es) * 1974-03-19 1976-10-15 Scherico Ltd Procedimiento para preparar derivados de diaminociclitole
JPS51143644A (en) * 1975-06-04 1976-12-10 Teijin Ltd A process for preparing kanamycin-n- polyhydroxyalkyl derivatives
GB1529243A (en) * 1976-02-25 1978-10-18 Pfizer Ltd Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein
DE2753769A1 (de) 1977-12-02 1979-06-13 Bayer Ag 1-n-4,6-di-o-(aminoglykosyl)-1,3- diamino-cyclitol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung
DE2832268A1 (de) * 1978-07-22 1980-01-31 Bayer Ag Pseudotrisaccharide
DE2921973A1 (de) * 1979-05-30 1980-12-11 Bayer Ag Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JPS57139093A (en) 1982-08-27
ES508803A0 (es) 1982-11-16
AU7885281A (en) 1982-07-29
EP0056575A1 (de) 1982-07-28
DE3101376A1 (de) 1982-09-02
DK16982A (da) 1982-07-18
US4438260A (en) 1984-03-20

Similar Documents

Publication Publication Date Title
ES8507535A1 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
ES8402591A1 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
ES8500932A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
ATE82681T1 (de) 2&#39;,3&#39;-dideoxy-3&#39;-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
JO1406B1 (en) Chemical compounds
ES8502989A1 (es) Un metodo de preparar compuestos de diaminopirimidina
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
ES8102147A1 (es) Procedimiento para la obtencion de derivados de sisomicina
ES8105991A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
IL66028A0 (en) Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
ES8203334A1 (es) Procedimiento para la obtencion de dehidropeptidos
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.